Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer of the PROSTATE”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT03322891
What this trial is testing

Improving Health Literacy in African-American Prostate Cancer Patients

Who this might be right for
Prostate Cancer
Emory University 210
Large-scale testing (Phase 3)WithdrawnNCT03488810
What this trial is testing

Apalutamide With Radiotherapy and Androgen Deprivation Therapy in Prostate Cancer

Who this might be right for
Prostate Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Testing effectiveness (Phase 2)Study completedNCT00777959
What this trial is testing

Bicalutamide and Ridaforolimus in Men With Prostate Cancer (MK-8669-002)

Who this might be right for
Prostate Cancer
Merck Sharp & Dohme LLC 22
Not applicableStudy completedNCT04638049
What this trial is testing

Intestinal Microbiota in Prostate Cancer Patients as a Biomarker for Radiation-INduced Toxicity (IMPRINT)

Who this might be right for
Prostate CancerProstate AdenocarcinomaProstatic Neoplasms
University Hospital, Ghent 50
Not applicableAvailableNCT06836648
What this trial is testing

Single Patient Compassionate Use of X-PACT in Salvage Treatment of Prostate Cancer

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Large-scale testing (Phase 3)Active Not RecruitingNCT02051218
What this trial is testing

Prevention of Symptomatic Skeletal Events With Denosumab Administered Every 4 Weeks Versus Every 12 Weeks

Who this might be right for
Metastatic Breast CancerMetastatic Prostate CancerBone Metastases
Swiss Cancer Institute 1,380
Large-scale testing (Phase 3)Not Yet RecruitingNCT07632690
What this trial is testing

QLC5508 in Participants With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Qilu Pharmaceutical Co., Ltd. 700
Testing effectiveness (Phase 2)Study completedNCT00091390
What this trial is testing

Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 129
Not applicableEnded earlyNCT04535908
What this trial is testing

Hypofractionated Radiotherapy in Prostate Cancer Patients Aged 75 Years or Older.

Who this might be right for
Prostate CancerRadiotherapy Side Effect
Medical University of Graz 23
Not applicableUnknownNCT04369508
What this trial is testing

PD-L1-expressing Regulatory T Cells in Localized Prostate Cancer Patients Undergoing Iodine-125 Permanent Brachytherapy

Who this might be right for
Prostate Cancer
Xuanwu Hospital, Beijing 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT03600350
What this trial is testing

PTVG-HP and Nivolumab in Patients With Non-Metastatic PSA-Recurrent Prostate Cancer

Who this might be right for
Prostate Cancer
University of Wisconsin, Madison 19
Not applicableStudy completedNCT01842438
What this trial is testing

A Couple Support Intervention for Prostate Cancer

Who this might be right for
Prostate Cancer
University of Stirling 86
Not applicableStudy completedNCT00032058
What this trial is testing

Magnetic Resonance Imaging and Magnetic Resonance Spectroscopic Imaging in Diagnosing the Extent of Disease in Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
American College of Radiology Imaging Network
Early research (Phase 1)Study completedNCT00250224
What this trial is testing

Prostate Localization During Radiotherapy Using a Ni-Ti Stent and Electronic Portal Imaging - Protocol II

Who this might be right for
Prostatic Neoplasms
Aalborg University Hospital 100
Not applicableLooking for participantsNCT05649943
What this trial is testing

Multimodal Approach in Patients With mHSPC. Randomized Trial of APA+ADT vs APA-ADT and Local Treatment

Who this might be right for
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 566
Not applicableStudy completedNCT02034825
What this trial is testing

Multi-site Decision Impact Study for Decipher

Who this might be right for
Prostate Cancer
GenomeDx Biosciences Corp 50
Testing effectiveness (Phase 2)Looking for participantsNCT06865768
What this trial is testing

An Investigational Scan (18F-rhPSMA-7.3 PET-mpMRI) for Targeted Prostate Biopsy Using TRUS-MR Fusion Technique

Who this might be right for
Prostate Carcinoma
Emory University 90
Testing effectiveness (Phase 2)Active Not RecruitingNCT03541850
What this trial is testing

Stereotactic Body Radiation Therapy in Treating Patients With Localized Prostate Cancer That Have Undergone Surgery

Who this might be right for
PSA Level Greater Than 0.03PSA ProgressionStage I Prostate Adenocarcinoma AJCC (American Joint Committee on Cancer ) v7+2 more
Jonsson Comprehensive Cancer Center 92
Testing effectiveness (Phase 2)WithdrawnNCT00694291
What this trial is testing

Sorafenib in Hormone Naïve Biochemical Recurrence of Prostate Cancer

Who this might be right for
Prostate Cancer
Fox Chase Cancer Center
Not applicableActive Not RecruitingNCT07048613
What this trial is testing

Comparative Study of MRI and TU in Identifying Clinically Significant Prostate Cancer Among Ethnic Groups

Who this might be right for
Prostate Cancer
Superior University 120
Next Page